Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus

Hybridoma

Volumn 18, Issue 5, 1999, Pages 413-421

  Alvi, Azhar Z ^a   Stadnyk, Laurie L ^b   Nagata, Les P ^b   Fulton, R Elaine ^b,d   Bader, Douglas E ^b   Roehrig, John T ^c   Suresh, Mavanur R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CFB Suffield   (Canada)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d Stn Main   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY 5B4D 6; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS GENE;

ALPHAVIRUS; EQUIDAE; ESCHERICHIA COLI; MURINAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0032732339     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1999.18.413     Document Type: Article

References (38)

1. Johnston RE, Peters CJ: Alphaviruses. In: Fields Virology, 3rd ed. Fields BN, Knipe DM, Howley PM, et al. (Eds.). Lippincott-Raven, Philadelphia, 1996, pp. 843-898.
2. Walton TE, and Grayson MA: Venezuelan equine encephalomyelitis. In: The Arboviruses: Epidemiology and Ecology. Monath TP (Ed.). CRC Press, Boca Raton, 1990, pp. 59-85.
3. Weaver SC, Salas R, Rico-Hesse R, Ludwig GV, Oberste MS, Boshell J, and Tesh RB: Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. VEE study group. Lancet 1996;348:436-440.
4. Schlesinger S, and Schlesinger MJ: Togaviridae: The viruses and their replication. In: Fields Virology, 3rd ed. Fields BN, Knipe DM, Howley PM et al. (Eds.). Lippincott-Raven, Philadelphia, 1996, pp. 825-841.
5. Strauss JH, and Strauss EG: The Alphaviruses: Gene expression, replication, and evolution. Microbiol Rev 1994;58:491-562.
6. Roehrig JT, Bolin RA, Hunt AR, and Woodward TM: Use of a new synthetic peptide derived monoclonal antibody to differentiate between vaccine and wild type Venezuelan equine encephalomyelitis viruses. J Clinical Microbiol 1991;29:630-631.
7. France JK, Wyrick BC, and Trent DW: Biochemical and antigenic comparisons of the envelope glycoproteins of Venezuelan equine encephalomyelitis virus strains. J Gen Virol 1979;44:725-740.
8. Roehrig JT, Day JW, and Kinney RM: Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology 1982;118: 269-278.
9. Mathews JH, and Roehrig JT: Determination of the protective epitopes on the glycoprotein of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol 1982;129:2763-2767.
10. Kohler G, and Milstein C: Continuous culture of fused cells secreting antibody of predefined specificity. Nature 1975;256: 495-497.
11. Roehrig JT, and Mathews JH: The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology 1985;142:347-356.
12. Hamilton RG: Monoclonal antibodies in the diagnosis and treatment of human diseases. A Biol Clin 1989;47:575-581.
13. Waldmann T: Monoclonal antibodies in diagnosis and therapy. Science 1991;252:1657-1662.
14. Ward SE, Gussow D, Griffiths AD, Jones PT, and Winter G: Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature 1989;341:544-546.
15. Sastry L, Alting-Mees M, Huse WD, Short JM, Sorge JA, Hay BN, Janda KD, Benkovic SJ, and Lerner RA: Cloning of the immunological repertoire in Escherichia coli for generation of monoclonal catalytic antibodies: Construction of a heavy chain variable region-specific cDNAs library. Proc Natl Acad Sci USA 1989;86: 5728-5732.
16. Better M, Chang CP, Robinson RR, and Horwitz AH: Escherichia coli secretion of an active chimeric antibody fragment. Science 1988;240:1041-1043.
17. Skerra A, and Pluckthun A: Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988; 240:1038-1041.
18. Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM, Lee T, Pope SH, Riordan GS, and Whitlow M: Single-chain antigen-binding proteins. Science 1988;242:423-426.
19. Bird RE, and Webb-Walker B: Single-chain antibody variable regions. Trends Biotechnol 1991;9:132-137.
20. Better M, and Horwitz AH: Expression of engineered antibodies and antibody fragments in microorganisms. Methods Enzymol 1989;178:466-496.
21. Chaudhary VK, Queen C, Junghans RP, Waldmann TA, Fitzgerald DJ, and Pastan I: A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 1989;399:394-397.
22. Denzin LK, and Voss EW Jr.: Construction, characterization, and mutagenesis of an anti-flourescein single-chain antibody idiotype family. J Biol Chem 1992;267:8925-8931.
23. Milenic DE, Yokota T, Filpula DR, Finkelman MAJ, Dodd SW, Wood JF, Whitlow M, Snoy P, and Schlom J: Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49. Cancer Res 1991;51:6363-6371.
24. Skerra A, Pfitzinger I, and Pluckthun A: The functional expression of antibody Fv fragment in Escherichia coli: Improved vectors and a generally applicable purification technique. Bio/Technol 1991;9:273-278.
25. Carrier A, Duncancel F, Settiawan NB, Cattolico L, Maillere B, Leonetti M, Drevet P, Menez A, and Boulain JC: Recombinant antibody-alkaline phosphatase conjugates for diagnosis of human IgGs: Application to anti HbsAg detection. J Immunol Methods 1995;181:177-186.
26. Furuta M, Uchikawa M, Ueda Y, Yabe T, Taima T, Tsumoto K, Kojima S, Juji T, and Kumagai I: Construction of mono- and bivalent human single-chain Fv fragments against the D antigen in the Rh blood group: Multimerization effect on cell agglutination and application to blood typing. Protein Eng 1998;11:233-241.
27. Lilley GG, Dolezal O, Hillyard CJ, Bernard C, and Hudson PJ: Recombinant single-chain antibody peptide conjugates expressed in Escherichia coli for rapid diagnosis of HIV. J Immunol Methods 1994;171:211-226.
28. Mason P: Cloning and expression of a single-chain antibody fragment specific for foot and mouth disease virus. Virology 1996;224:548-554.
29. Froyen G, Ronsse I, and Billiau A: Bacterial expression of a single-chain antibody fragment (ScFv) that neutralizes the biological activity of human interferon-gamma. Mol Immunol 1993;30: 805-812.
30. Shibata Y, Kurihara K, Takiguchi H, and Abiko Y: Construction of a functional single-chain variable fragment antibody against hemagglutinin from Porphymonas gingivalis. Infect Immun 1998;66:2207-2212.
31. Harper K, Kerschbaumer RJ, Ziegler A, Macintosh SM, Cowan GH, Himmler G, Mayo MA, and Torrance L: A ScFv-alkaline phosphatase fusion protein which detects potato leafroll luteovirus in plant extracts by ELISA. J Virol Methods 1997;63:237-242.
32. Jonge JD, Heirman C, Veerman MD, Meirvenne SV, Moser M, Leo O, and Thielemans K: In vivo retargeting of T cell effector function by recombinant bispecific single-chain Fv (anti-CD3X anti-idiotype) induces long-term survival in the murine BCL1 lymphoma model. J Immunol 1998;161:1454-1461.
33. Pauza ME, Doumbia SO, and Pencil CA: Construction and characterization of human CD7 specific single-chain Fv immunotoxins. J Immunol 1997;158:3259-3269.
34. MacKenzie CR, Clark ID, Evans SV, Hill IE, MacManus JP, Dubuc G, Bundle DR, Narang SA, Young NM, and Szabo AG: Bifunctional fusion proteins consisting of a single-chain antibody and an engineered lanthanide-binding protein. Immonotechnology 1995; 1:139-150.
35. Sambrook J, Fritsch EF, and Maniatis T: Molecular cloning, A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989.
36. Kabat EA, Wu TT, Perry HM, Gottesman KS, and Foeller C: Sequences of proteins of immunological interest, 5th ed. U.S. Department of Health and Human Services. Public Health Service, National Institutes of Health. Bethesda, MD, 1991.
37. Johnson BJB, Brubaker JR, Roehrig JT, and Trent DW: Variants of the Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology 1990;177: 676-683.
38. Ward ES: Antibody engineering using Escherichia coli as host. Adv Pharmacol 1993;24:1-20.